A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia

201443 citationsJournal Article

Authors

OnabotulinumtoxinA 200 U and placebo improved I-PSS and were well tolerated but no between group difference in efficacy was observed.

Partnerships for the goals

Published in: The Journal of Urology

Volume 192, Issue 1, pp. 150-156

Field-Weighted Citation Impact: 5.89